NCT00550693View on ClinicalTrials.gov

Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

March 31, 2005

Conditions
Catheter Related Bloodstream Infection
Interventions
DEVICE

Chlorhexidine-impregnated foam dressing

Patients during the intervention period had this foam dressing applied around their central venous catheter. This was replaced once a week as recommended by the package insert unless the dressing was soiled, bloody, or fell off.

Trial Locations (2)

63108

Barnes-Jewish Dialysis Center, St Louis

63110

Chromalloy American Kidney Center, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00550693 - Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients | Biotech Hunter | Biotech Hunter